Syschem India Ltd

BSE: 531173
Compare with peers
₹ 36.86▲ 1 (+2.79%)28 Oct, 03:29 pm IST
Market cap
₹ 169 Cr.
P/E
27.1x
P/B
1.31x
52-week range
28.81 – 60.95
ROE
10%
ROCE
16%
Dividend yield
0%
Debt / equity
0
Sector
Pharmaceuticals & Biotechnology
Industry
Pharmaceuticals
Listed on
BSE

About

Syschem (India) Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredient (API) / Intermediates. The Company operates through pharmaceuticals segment. The Company’s API/ Intermediates products include Amoxycillin Trihydrate; Ampicillin Trihydrate; Cloxacillin Sodium; Dicloxacillin Sodium; Flucloxacillin Sodium for export only; Cephalexin; Cefixime; Cefadroxil; Distillation of Specialty Solvents, such as dimethylformamide (DMF), acetonitrile, ethyl acetate and tetrahydrofuran (THF). It also engaged in the manufacturing of bulk drugs/ intermediates / specialty chemicals and contract manufacturing. The Company has its manufacturing facility at Village Bargodam, Tehsil Kalka, Distt. Panchkula Haryana.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Pharmaceuticals: 221 companies →

Syschem India Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)27.1 against a typical 34: cheaper than most peers (1st = cheapest).90th of 220
  • Sales growth−0.1% against a typical +15.6% from a year earlier.149th of 197
  • Profit growth−200% against a typical +18.9% from a year earlier.155th of 160
  • Share price, 3 months−11.3% against a typical −0.5%.151st of 200
  • Size₹ 168.9 Cr. market value against a typical ₹ 507.7 Cr. (1st = largest).126th of 199

Share price

1Y change −32.61%
Volume (shares)Price (₹)
Close price

Financials

Standalone figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales374475884878119109104142219109
Expenses354373874777117107100136210109
Operating Profit212101223691
OPM %5%2.5%2.2%0.9%0.2%1.5%1.6%2.3%3.2%4.2%4.3%0.5%
Other Income000000000000
Interest000000000020
Depreciation111111111122
Profit before tax1010−1112356−1
Tax %0%0%123.9%0%0%0%54.5%0%25.6%15.9%68.9%15.1%
Net Profit10−00−1102242−2
EPS in Rs0.280.06−0.070.04−0.160.130.110.380.440.960.36−0.34

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
66%
5 Years
53%
3 Years
72%
TTM
62%
Compounded Profit Growth
10 Years
21%
5 Years
32%
3 Years
34%
TTM
209%
Stock Price CAGR
10 Years
17%
5 Years
31%
3 Years
−17%
TTM
—
Return on Equity
10 Years
4%
5 Years
7%
3 Years
6%
TTM
—

Shareholding

Latest: Jul 2026.

Promoters
63.38%
+6.67 pts in a year
DIIs
0.15%
−0.03 pts in a year
Public
36.47%
−6.64 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 27.1xEPS (12 months) ₹ 1.41Median P/E 37.9x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Syschem India Ltd₹ 36.86₹ 169 Cr.27.1x1.3x10%—
Asian Paints₹ 2,305.00₹ 2,21,095 Cr.58.1x12.1x21.2%12.4%
Solar Industries India₹ 18,320.00₹ 1,65,778 Cr.99.6x26.6x31.4%17.7%
Pidilite Industries₹ 1,514.00₹ 1,54,107 Cr.64.8x14.7x23.8%16.9%
SRF₹ 2,309.00₹ 68,444 Cr.44.6x6.1x13.8%11.6%
Linde India₹ 5,697.00₹ 48,586 Cr.110.5x14.2x13.6%21.7%

Management

Suninder Veer Singh
Whole Time Chairman of the Board, Managing Director
Sanjeev Agrawal
Chief Financial Officer
Shikha Kataria
Compliance Officer, Company Secretary
Ranjan Jain
Managing Director, Whole Time Director

Prices are delayed and for information only. Nothing on this page is investment advice.